Scarica l'app Stockscreener
90.81
0.86%
-0.79
Dopo l'orario di chiusura:
90.81
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché EW Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$91.60
Aprire:
$90.84
Volume 24 ore:
2.25M
Relative Volume:
0.47
Capitalizzazione di mercato:
$52.34B
Reddito:
$6.30B
Utile/perdita netta:
$1.07B
Rapporto P/E:
49.34
EPS:
1.8406
Flusso di cassa netto:
$1.09B
1 W Prestazione:
-1.33%
1M Prestazione:
+5.93%
6M Prestazione:
+15.76%
1 anno Prestazione:
+16.04%
Intervallo 1D:
$90.59
$91.58
Intervallo di 1 settimana:
$90.59
$93.91
Portata 52W:
$72.30
$96.29
Edwards Lifesciences Corp Stock (EW) Company Profile
Nome
Edwards Lifesciences Corp
Settore
Industria
Telefono
(949) 250-2500
Indirizzo
ONE EDWARDS WAY, IRVINE, CA
Compare EW vs ABT, SYK, MDT, BSX
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
EW
Edwards Lifesciences Corp
|
90.81 | 52.80B | 6.30B | 1.07B | 1.09B | 1.8406 |
ABT
Abbott Laboratories
|
110.37 | 192.51B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
331.68 | 130.11B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
90.60 | 116.83B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
51.43 | 75.11B | 20.62B | 3.56B | 3.48B | 2.3847 |
Edwards Lifesciences Corp Stock (EW) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-04-01 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2026-01-09 | Aggiornamento | TD Cowen | Hold → Buy |
| 2025-12-18 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2025-11-03 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2025-10-29 | Aggiornamento | Jefferies | Hold → Buy |
| 2025-10-29 | Aggiornamento | Wolfe Research | Underperform → Peer Perform |
| 2025-10-08 | Downgrade | Oppenheimer | Outperform → Perform |
| 2025-10-07 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2025-07-29 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2025-04-24 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2025-01-30 | Aggiornamento | Stifel | Hold → Buy |
| 2025-01-16 | Downgrade | Wolfe Research | Peer Perform → Underperform |
| 2024-12-16 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2024-10-11 | Ripresa | Morgan Stanley | Equal-Weight |
| 2024-09-18 | Downgrade | Jefferies | Buy → Hold |
| 2024-07-31 | Aggiornamento | Daiwa Securities | Neutral → Outperform |
| 2024-07-29 | Aggiornamento | Wolfe Research | Underperform → Peer Perform |
| 2024-07-25 | Downgrade | BofA Securities | Buy → Neutral |
| 2024-07-25 | Downgrade | JP Morgan | Overweight → Neutral |
| 2024-07-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2024-07-25 | Downgrade | TD Cowen | Buy → Hold |
| 2024-07-25 | Downgrade | Truist | Buy → Hold |
| 2024-05-30 | Iniziato | Goldman | Buy |
| 2024-05-22 | Aggiornamento | Citigroup | Neutral → Buy |
| 2024-05-14 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2024-03-07 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2024-02-02 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2024-01-04 | Downgrade | Evercore ISI | Outperform → In-line |
| 2023-12-11 | Downgrade | Citigroup | Buy → Neutral |
| 2023-11-28 | Downgrade | Wolfe Research | Peer Perform → Underperform |
| 2023-09-26 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2023-07-19 | Iniziato | Robert W. Baird | Outperform |
| 2023-05-30 | Ripresa | Morgan Stanley | Overweight |
| 2023-03-29 | Iniziato | UBS | Neutral |
| 2023-03-08 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2023-02-06 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2023-01-31 | Downgrade | Bernstein | Outperform → Underperform |
| 2023-01-30 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2022-12-06 | Downgrade | Stifel | Buy → Hold |
| 2022-10-28 | Downgrade | Oppenheimer | Outperform → Perform |
| 2022-10-26 | Iniziato | Mizuho | Buy |
| 2022-10-18 | Iniziato | Barclays | Overweight |
| 2022-10-12 | Iniziato | Jefferies | Buy |
| 2022-07-29 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2022-04-13 | Iniziato | Truist | Buy |
| 2022-04-06 | Iniziato | Wolfe Research | Outperform |
| 2022-03-16 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
| 2022-03-02 | Ripresa | BofA Securities | Neutral |
| 2022-02-02 | Aggiornamento | UBS | Neutral → Buy |
| 2022-01-27 | Reiterato | Citigroup | Buy |
| 2022-01-27 | Reiterato | Evercore ISI | Outperform |
| 2022-01-27 | Reiterato | Raymond James | Outperform |
| 2022-01-27 | Reiterato | Stifel | Buy |
| 2022-01-27 | Reiterato | UBS | Neutral |
| 2021-12-17 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2021-12-15 | Aggiornamento | Citigroup | Neutral → Buy |
| 2021-12-10 | Iniziato | RBC Capital Mkts | Outperform |
| 2021-12-06 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2021-07-30 | Reiterato | Canaccord Genuity | Buy |
| 2021-07-30 | Reiterato | Deutsche Bank | Hold |
| 2021-07-30 | Reiterato | Jefferies | Buy |
| 2021-07-30 | Reiterato | Morgan Stanley | Overweight |
| 2021-07-30 | Reiterato | Oppenheimer | Outperform |
| 2021-07-30 | Reiterato | Stifel | Buy |
| 2021-07-30 | Reiterato | UBS | Neutral |
| 2021-07-30 | Reiterato | Wells Fargo | Equal Weight |
| 2021-05-25 | Iniziato | Barclays | Overweight |
| 2021-04-15 | Iniziato | Atlantic Equities | Neutral |
| 2021-04-05 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2020-12-16 | Downgrade | Citigroup | Buy → Neutral |
| 2020-12-11 | Reiterato | Canaccord Genuity | Buy |
| 2020-09-11 | Iniziato | Wolfe Research | Underperform |
| 2020-04-28 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2020-04-17 | Aggiornamento | SVB Leerink | Mkt Perform → Outperform |
| 2020-03-05 | Iniziato | Citigroup | Buy |
| 2020-02-13 | Iniziato | Goldman | Neutral |
| 2020-02-06 | Ripresa | BTIG Research | Neutral |
| 2020-01-10 | Iniziato | Oppenheimer | Outperform |
| 2020-01-02 | Downgrade | Evercore ISI | Outperform → In-line |
| 2019-10-24 | Reiterato | Canaccord Genuity | Buy |
| 2019-09-23 | Iniziato | Piper Jaffray | Overweight |
| 2019-07-24 | Reiterato | BofA/Merrill | Buy |
| 2019-03-18 | Reiterato | Canaccord Genuity | Buy |
| 2019-01-18 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2019-01-03 | Iniziato | Deutsche Bank | Hold |
| 2018-11-28 | Iniziato | UBS | Neutral |
| 2018-10-16 | Iniziato | Barclays | Underweight |
| 2018-10-02 | Downgrade | BofA/Merrill | Buy → Neutral |
| 2018-10-02 | Downgrade | Guggenheim | Buy → Neutral |
Mostra tutto
Edwards Lifesciences Corp Borsa (EW) Ultime notizie
Oppenheimer Asset Management Inc. Purchases Shares of 22,090 Edwards Lifesciences Corporation $EW - MarketBeat
AMG National Trust Bank Invests $6.83 Million in Edwards Lifesciences Corporation $EW - MarketBeat
Maridea Wealth Management LLC Purchases New Position in Edwards Lifesciences Corporation $EW - MarketBeat
Bank Hapoalim BM Makes New $1.78 Million Investment in Edwards Lifesciences Corporation $EW - MarketBeat
Empowered Funds LLC Boosts Stock Position in Edwards Lifesciences Corporation $EW - MarketBeat
ABN AMRO Bank N.V. Makes New $83.57 Million Investment in Edwards Lifesciences Corporation $EW - MarketBeat
Everett Harris & Co. CA Acquires Shares of 80,341 Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences Corp. stock underperforms Friday when compared to competitors - MarketWatch
EW|Edwards Lifesciences Corp|Price:90.865|Chg%:-0.735 - tradingkey.com
Seascape Capital Management's Edwards Lifesciences Corp(EW) Holding History - GuruFocus
Is Wall Street Bullish or Bearish on Edwards Lifesciences Stock? - Yahoo Finance
Edwards Lifesciences CVP sells $56,966 in company stock By Investing.com - Investing.com Australia
Edwards Lifesciences CVP sells $56,966 in company stock - Investing.com
Edwards Lifesciences (EW) Insider Daniel Lippis Sells 619 Shares - GuruFocus
EW News | EDWARDS LIFESCIENCES CORP (NYSE:EW) - ChartMill
Daniel Lippis Sells 619 Shares of Edwards Lifesciences (NYSE:EW) Stock - MarketBeat
Edwards Lifesciences Corp. stock outperforms competitors on strong trading day - MarketWatch
Edwards Lifesciences (EW) insider files Form 144 for cashless option exercise - Stock Titan
Handelsbanken Fonder AB Has $139.42 Million Holdings in Edwards Lifesciences Corporation $EW - MarketBeat
29,000 Shares in Edwards Lifesciences Corporation $EW Bought by Renaissance Technologies LLC - marketbeat.com
Edwards Lifesciences Corporation $EW is Seilern Investment Management Ltd's 4th Largest Position - MarketBeat
Orser Capital Management LLC Invests $2.32 Million in Edwards Lifesciences Corporation $EW - MarketBeat
Assenagon Asset Management S.A. Acquires 547,212 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences Corporation (NYSE:EW) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
Fund Update: 525,889 EDWARDS LIFESCIENCES (EW) shares added to ABN AMRO Bank N.V. portfolio - quiverquant.com
Segall Bryant & Hamill LLC Acquires New Stake in Edwards Lifesciences Corporation $EW - MarketBeat
EW CLASS ACTION FINAL DEADLINE: Edwards Lifesciences Investors are Notified that Today is the Final Deadline in Securities Fraud Class Action and are Urged to Contact BFA Law - TMX Newsfile
Edwards Lifesciences (EW) Has a Growth Runway Competitors May Struggle to Match - Yahoo Finance
Is It Too Late to Buy Edwards Lifesciences Corp (EW) After 3.2% Rally? GF Value Says Undervalued - GuruFocus
Bank of America Corp DE Acquires 2,212,208 Shares of Edwards Lifesciences Corporation $EW - marketbeat.com
Groupama Asset Managment Purchases New Position in Edwards Lifesciences Corporation $EW - marketbeat.com
Janus Henderson Group PLC Boosts Stake in Edwards Lifesciences Corporation $EW - MarketBeat
California State Teachers Retirement System Sells 34,344 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
Liontrust Investment Partners LLP Trims Stock Position in Edwards Lifesciences Corporation $EW - MarketBeat
Form 4 Edwards Lifesciences Corp For: 30 July By Investing.com - Investing.com Canada
Edwards Lifesciences Corp. stock rises Thursday, still underperforms market - MarketWatch
Healthcare of Ontario Pension Plan Trust Fund Acquires 69,169 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences Corporation $EW Holdings Lifted by First Trust Advisors LP - MarketBeat
UBS initiates Edwards Lifesciences stock coverage with buy rating By Investing.com - Investing.com Nigeria
UBS Group Begins Coverage on Edwards Lifesciences (NYSE:EW) - MarketBeat
Form 4 Edwards Lifesciences Corp For: 27 July By Investing.com - Investing.com Nigeria
Edwards Lifesciences CEO Bernard Zovighian sells $245,134 in shares - Investing.com
Form 144 Edwards Lifesciences Corp For: 27 July By Investing.com - Investing.com South Africa
Form 144 Edwards Lifesciences Corp For: 27 July - Investing.com India
EW|Edwards Lifesciences Corp|Price:83.040|Chg%:+0.410 - TradingKey
Edwards Lifesciences (EW)’s TMTT Revenue Surges 47%: Can Rapid Growth Drive the Next Leg of Earnings Expansion? - Yahoo Finance Singapore
Edwards Lifesciences (EW) insider Zovighian details recent $2.83M stock sale in Form 144 - Stock Titan
Edwards Lifesciences Corp (EW) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Edwards Lifesciences stock trades steady as TAVR growth supports margins - Ad-hoc-news.de
Edwards Lifesciences Corporation $EW Shares Purchased by Arrowstreet Capital Limited Partnership - MarketBeat
ETFs Investing in Edwards Lifesciences Corporation Stocks - TradingView
Edwards Lifesciences Corp Azioni (EW) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.10%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):